报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 69.68% | -12.96% | 2.28% | 30/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 68.13% | -18.44% | 16.86% | 40/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 58.3% | -31.8% | -27.08% | 59/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 79.95% | -11.34% | -0.13% | 9/129 | 53.85% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 80.06% | -11.19% | -4.16% | 11/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 83.53% | -7.48% | -2.28% | 4/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 85.48% | -5.79% | -5.2% | 3/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 90.18% | -0.36% | 0.04% | 1/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 90.14% | -0.17% | -0.16% | 1/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 90.29% | -0.27% | -0.49% | 1/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 90.73% | 1.32% | 0.26% | 1/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 90.5% | -0.41% | 0.23% | 1/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 90.29% | -0.37% | -0.27% | 1/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 90.54% | -0.61% | 1.1% | 2/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2021-03-31 | 89.55% | 0.68% | -1.46% | 2/129 | 60.75% | 正海生物 | 91.59% | 行业排名> |
2020-12-31 | 90.87% | -0.43% | 0.27% | 2/129 | 59.67% | 正海生物 | 92.23% | 行业排名> |
2020-09-30 | 90.63% | 2% | -0.5% | 2/129 | 61.59% | 正海生物 | 92.69% | 行业排名> |
2020-06-30 | 91.09% | -0.73% | 2.41% | 2/129 | 59.94% | 正海生物 | 92.61% | 行业排名> |
2020-03-31 | 88.95% | 2% | -2.54% | 3/129 | 58.33% | 正海生物 | 94.38% | 行业排名> |
2019-12-31 | 91.26% | 3.07% | -0.54% | 2/129 | 56.37% | 正海生物 | 93.12% | 行业排名> |
2019-06-30 | 91.75% | 2% | 3.62% | 2/129 | 57.37% | 正海生物 | 93.78% | 行业排名> |
2018-12-31 | 88.55% | 13.19% | 13.19% | 4/129 | 55.53% | 正海生物 | 93.09% | 行业排名> |
2017-12-31 | 78.23% | 3.91% | 3.91% | 17/129 | 55.34% | 正海生物 | 93.85% | 行业排名> |
2016-12-31 | 75.29% | 2% | 2% | 18/129 | 56.43% | 正海生物 | 93.08% | 行业排名> |